In general, multi-center studies of TCHM are increasing with years, but most of the studies are performed in some certain country, and the actual international multi-center clinical trials are very rare. Since, a variety of drug products in China have been approved for marketing in other countries, and approximately 10 products have submitted the IND application to FDA of United States, of which various Chinese herbal preparations such as compound Danshen dripping pills, Xingling granules, and HMPL-004 have been approved to be investigated in phase III clinical trials. With the introduction of various subjects, such as clinical epidemiology and evidence-based medicine, the qualities and levels of Traditional Chinese Herbal Medicine (TCHM) in China improved substantially, and the processes of internationalization of Traditional Chinese Medicine (TCM) are further accelerated. 4Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.3China Science and Technology Development Center of Chinese Medicine, Beijing, China.2Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medicine Science, Beijing, China. 1Xin-Huangpu Joint Innovation Institute of Chinese Medicine, Guangzhou, China. Shan Wu 1,2 † Chuanchi Wang 1,3 † Dong Bai 2 † Nanjie Chen 2 Jingqing Hu 3* Junhua Zhang 4*
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |